Methods for oxysterol analysis: Past, present and future

Biochemical Pharmacology

Volumn 86, Issue 1, 2013, Pages 3-14

  Griffiths, William J ^a   Crick, Peter J ^a   Wang, Yuqin ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Autoxidation; Cholestenoic acid; Cholesterol; Derivatisation; Mass spectrometry; Sterol

Indexed keywords

OXYGEN; OXYSTEROL; REACTIVE OXYGEN METABOLITE; STEROL;

ATHEROSCLEROSIS; AUTOOXIDATION; CEREBROSPINAL FLUID; DERIVATIZATION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFLAMMATORY DISEASE; NERVOUS SYSTEM DEVELOPMENT; OXIDATION; PRIORITY JOURNAL; PROTEIN PRENYLATION; REVIEW; STEROL ANALYSIS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; OXIDATION REDUCTION REACTION; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY;

CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, THIN LAYER; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; OXIDATION-REDUCTION; STEROLS; TANDEM MASS SPECTROMETRY;

EID: 84884306056     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.01.027     Document Type: Review

References (62)

1. Javitt NB. Oxysterols: novel biologic roles for the 21st century. Steroids 2008;73:149-57.
2. Schroepfer Jr GJ. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000;80:361-554. (Pubitemid 30060568)
3. Hovenkamp E, Demonty I, Plat J, Lutjohann D, Mensink RP, Trautwein EA. Biological effects of oxidized phytosterols: a review of the current knowledge. Prog Lipid Res 2008;47:37-49. (Pubitemid 350216621)
4. Bergström S, Wintersteiner O. Autoxidation of sterols in colloidal aqueous solution. The nature of the products formed from cholesterol. J Biol Chem 1941;141:597-610.
5. Bergström S, Wintersteiner O. Autoxidation of sterols in colloidal aqueous solution II. J Biol Chem 1942;143:503-7.
6. Smith LL. Cholesterol autoxidation. New York, NY: Plenum Press; 1981.
7. Kudo K, Emmons GT, Casserly EW, Via DP, Smith LC, St PJ, et al. Inhibitors of sterol synthesis. Chromatography of acetate derivatives of oxygenated sterols. J Lipid Res 1989;30:1097-111. (Pubitemid 19183962)
8. Breuer O, Björkhem I. Use of an 18O2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7-oxo-, 7 beta-hydroxy-, 24-hydroxy-, and 25-hydroxycholesterol. J Biol Chem 1995;270:20278-84.
9. Bjö rkhem I, Diczfalusy U, Olsson T, Russell DW, McDonald JG, Wang Y, et al. Detecting oxysterols in the human circulation. Nat Immunol 2011;12: 577-8.
10. Diestel A, Aktas O, Hackel D, Hake I, Meier S, Raine CS, et al. Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J Exp Med 2003;198:1729-40. (Pubitemid 37494165)
11. Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol 2009;10: 958-64.
12. Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 2007;104:6511-8. (Pubitemid 47175533)
13. Wong J, Quinn CM, Gelissen IC, Brown AJ. Endogenous 24(S),25- epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J Biol Chem 2008;283:700-7.
14. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-31. (Pubitemid 26360651)
15. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137-40. (Pubitemid 27066798)
16. Wang Y, Kumar N, Crumbley C, Griffin PR, Burris TP. A second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim Biophys Acta 2010;1801:917-23.
17. Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, Pereira JP, et al. Oxysterols direct immune cell migration via EBI2. Nature 2011;475:524-7.
18. Liu C, Yang XV, Wu J, Kuei C, Mani NS, Zhang L, et al. Oxysterols direct B-cell migration through EBI2. Nature 2011;475:519-23.
19. Bauman DR, Bitmansour AD, McDonald JG, Thompson BM, Liang G, Russell DW. 25-Hydroxycholesterol secreted by macrophages in response to toll-like receptor activation suppresses immunoglobulin A production. Proc Natl Acad Sci USA 2009;106:16764-69.
20. Blanc M, Hsieh WY, Robertson KA, Kropp KA, Forster T, Shui G, et al. The transcription factor STAT-1 couples macrophage synthesis of 25- hydroxycholesterol to the interferon antiviral response. Immunity 2012;38:106-18.
21. Björkhem I, Cedazo-Minguez A, Leoni V, Meaney S. Oxysterols and neurodegenerative diseases. Mol Aspects Med 2009;30:171-9.
22. Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, et al. Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med 2004;42:186-91. (Pubitemid 38401447)
23. Sacchetti P, Sousa KM, Hall AC, Liste I, Steffensen KR, Theofilopoulos S, et al. Liver receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell 2009;5:409-19.
24. Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995;225:73-80.
25. Teng JI, Smith LL. High-performance liquid chromatographic analysis of human erythrocyte oxysterols as delta 4-3-ketone derivatives. J Chromatogr A 1995;691:247-54.
26. Zhang Z, Li D, Blanchard DE, Lear SR, Erickson SK, Spencer TA. Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. J Lipid Res 2001;42:649-58. (Pubitemid 32367008)
27. Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill Jr AH, Murphy RC, et al. A comprehensive classification system for lipids. J Lipid Res 2005;46:839-61.
28. Heverin M, Bogdanovic N, Lü tjohann D, Bayer T, Pikuleva I, Bretillon L, et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 2004;45:186-93. (Pubitemid 38180529)
29. Mast N, Norcross R, Andersson U, Shou M, Nakayama K, Björkhem I, et al. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 2003;42:14284-92. (Pubitemid 37499426)
30. Leoni V, Lü tjohann D, Masterman T. Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J Lipid Res 2005;46:191-5. (Pubitemid 40271081)
31. Lü tjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 1996;93:9799-804. (Pubitemid 26296689)
32. McDonald JG, Smith DD, Stiles AR, Russell DW. A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. J Lipid Res 2012;53:1399-409.
33. Honda A, Yamashita K, Hara T, Ikegami T, Miyazaki T, Shirai M, et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J Lipid Res 2009;50:350-7.
34. Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 2010;51:3299-305.
35. Burkard I, Rentsch KM, von EA. Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. J Lipid Res 2004;45:776-81. (Pubitemid 38405686)
36. DeBarber AE, Lü tjohann D, Merkens L, Steiner RD. Liquid chromatography- tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. Anal Biochem 2008;381:151-3.
37. van de Merbel NC, Bronsema KJ, van Hout MW, Nilsson R, Sillen H. A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4beta-hydroxycholesterol in human plasma. J Pharm Biomed Anal 2011;55:1089-95.
38. Xu L, Davis TA, Porter NA. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc 2009;131:13037-44.
39. Liu W, Xu L, Lamberson CR, Merkens LS, Steiner RD, Elias ER, et al. Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients. J Lipid Res 2013;54:244-53.
40. Shinkyo R, Xu L, Tallman KA, Cheng Q, Porter NA, Guengerich FP. Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J Biol Chem 2011;286:33021-28.
41. Björkhem I, Starck L, Andersson U, Lü tjohann D, von BS, Pikuleva I, et al. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol. J Lipid Res 2001;42:366-71. (Pubitemid 32270060)
42. Honda A, Yamashita K, Miyazaki H, Shirai M, Ikegami T, Xu G, et al. Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS. J Lipid Res 2008;49:2063-73.
43. Ikegami T, Hyogo H, Honda A, Miyazaki T, Tokushige K, Hashimoto E, et al. Increased serum liver receptor ligand oxysterols in patients with nonalcoholic fatty liver disease. J Gastroenterol 2012;47:1257-66.
44. Jiang X, Ory DS, Han X. Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. Rapid Commun Mass Spectrom 2007;21:141-52. (Pubitemid 46095472)
45. Jiang X, Sidhu R, Porter FD, Yanjanin NM, Speak AO, te Vruchte DT, et al. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 2011;52:1435-45.
46. Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2010;2:56ra81.
47. Girard A, Sandulesco G. Sur une nouvelle serie de reactifs du groupe carbonyle, leur utilisation a l'extraction des substances cetoniques et a la caracte risation microchimique des aldehydes et cetones. Helv Chim Acta 1936;19:1095.
48. Shackleton CH, Chuang H, Kim J, de lT X, Segura J. Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 1997;62:523-9. (Pubitemid 27319201)
49. Karu K, Hornshaw M, Woffendin G, Bodin K, Hamberg M, Alvelius G, et al. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J Lipid Res 2007;48:976-87. (Pubitemid 46562412)
50. Karu K, Turton J, Wang Y, Griffiths WJ. Nano-liquid chromatography-tandem mass spectrometry analysis of oxysterols in brain: monitoring of cholesterol autoxidation. Chem Phys Lipids 2011;164:411-24.
51. Meljon A, Theofilopoulos S, Shackleton CH, Watson GL, Javitt NB, Knolker HJ, et al. Analysis of bioactive oxysterols in newborn mouse brain by LC/MS. J Lipid Res 2012;53:2469-83.
52. Wang Y, Sousa KM, Bodin K, Theofilopoulos S, Sacchetti P, Hornshaw M, et al. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. Mol Biosyst 2009;5:529-41.
53. Griffiths WJ, Hornshaw M, Woffendin G, Baker SF, Lockhart A, Heidelberger S, et al. Discovering oxysterols in plasma: a window on the metabolome. J Proteome Res 2008;7:3602-12.
54. Griffiths WJ, Crick PJ, Wang Y, Ogundare M, Tuschl K, Morris AA, et al. Analytical strategies for characterization of oxysterol lipidomes: liver recepreceptor ligands in plasma. Free Radic Biol Med 2012. in press..
55. Ogundare M, Theofilopoulos S, Lockhart A, Hall LJ, Arenas E, Sjovall J, et al. Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain? J Biol Chem 2010;285:4666-79.
56. MacLachlan J, Wotherspoon AT, Ansell RO, Brooks CJ. Cholesterol oxidase: sources, physical properties and analytical applications. J Steroid Biochem Mol Biol 2000;72:169-95. (Pubitemid 30261523)
57. DeBarber AE, Sandlers Y, Pappu AS, Merkens LS, Duell PB, Lear SR, et al. Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis. J Chromatogr B Anal Technol Biomed Life Sci 2011;879:1384-92.
58. Roberg-Larsen H, Strand MF, Grimsmo A, Olsen PA, Dembinski JL, Rise F, et al. High sensitivity measurements of active oxysterols with automated filtration/ filter backflush-solid phase extraction-liquid chromatography-mass spectrometry. J Chromatogr A 2012;1255:291-7.
59. Bodin K, Bretillon L, Aden Y, Bertilsson L, Broome U, Einarsson C, et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 2001;276:38685-89.
60. Axelson M, Sjovall J. Potential bile acid precursors in plasma - possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J Steroid Biochem 1990;36:631-40. (Pubitemid 20283899)
61. Meaney S, Heverin M, Panzenboeck U, Ekstrom L, Axelsson M, Andersson U, et al. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. J Lipid Res 2007;48:944-51. (Pubitemid 46557899)
62. Axelson M, Mork B, Sjovall J. Occurrence of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid, and 7 alpha-hydroxy-3- oxo-4-cholestenoic acid as normal constituents in human blood. J Lipid Res 1988;29:629-41.